Figure 2From: ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer Increased nuclear ERβ1 expression is associated with prolonged recurrence-free interval in women treated with adjuvant tamoxifen and fluoxymesterone therapy. Kaplan-Meier estimates of breast cancer recurrence-free interval in patients with negative/low, moderate or high nuclear expression of ERβ1 are shown.Back to article page